Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 60.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,278 shares of the medical equipment provider's stock after acquiring an additional 3,118 shares during the quarter. HighPoint Advisor Group LLC's holdings in Intuitive Surgical were worth $4,262,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Chilton Capital Management LLC boosted its stake in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the period. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Global Financial Private Client LLC boosted its stake in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the period. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical in the 1st quarter valued at about $26,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ISRG. BTIG Research set a $566.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, July 14th. Citigroup restated a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Royal Bank Of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $592.86.

Intuitive Surgical Stock Down 1.0%

ISRG stock traded down $5.12 on Tuesday, reaching $511.00. 2,403,865 shares of the company's stock were exchanged, compared to its average volume of 1,669,165. The stock has a fifty day moving average of $535.90 and a 200-day moving average of $536.29. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market cap of $183.15 billion, a PE ratio of 74.93, a P/E/G ratio of 5.50 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the previous year, the business earned $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director owned 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 over the last three months. Insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.